Skip to main navigation Skip to search Skip to main content

The E. coli lite strains: New expression strains for the production of toxic membrane proteins

  • Alexandra E Trigg
  • , Parisa Pordelkhaki
  • , Ksenia M Klimova
  • , Adam T Wood
  • , Joanne Hothersall
  • , Stephen J W Busby
  • , Tim W Overton
  • , Douglas F Browning
  • Aston University
  • University of Birmingham

Research output: Contribution to journal › Article › peer-review

1 Downloads (Pure)

Abstract

The production of recombinant biopharmaceuticals is a billion-dollar industry, with numerous high-value proteins expressed in the bacterium Escherichia coli. Many recombinant protein production (RPP) systems enable the synthesis and purification of large amounts of soluble recombinant protein. However, such systems are often too strong to allow the expression of difficult-to-fold proteins, such as membrane proteins, with high-level RPP resulting in the production of insoluble aggregates (i.e., inclusion bodies), target protein degradation and even cell death. To aid the production of problematic proteins, we have engineered the E. coli lite strains in which the plasmid copy number regulator pcnB has been disrupted to allow expression levels of protein targets to be immediately lowered. Using the E. coli lite strains, we express a variety of proteins including green fluorescent protein (GFP), human growth hormone (hGH) and three toxic membrane proteins (BamAENm, LetBEPEC and YiaM). We show that the E. coli lite strains are able to substantially lower the expression of target proteins and alleviate the cellular toxicity associated with producing membrane-localised proteins. Additionally, we show that the E. coli lite strains are extremely versatile, functioning with a variety of RPP systems, including lac-, T7 RNA polymerase- and paraBAD-based systems, and operate under different expression and growth regimes. Thus, the E. coli lite strains can be used to quickly lower expression levels of complicated target proteins to improve both protein production and cell growth.

Original languageEnglish
Pages (from-to)206-215
Number of pages10
JournalNew Biotechnology
Volume96
Early online date23 Oct 2026
DOIs
Publication statusE-pub ahead of print - 23 Oct 2026

Bibliographical note

© 2026 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ).

Data Access Statement

All data relating to this article are present in the article and the accompanying Supplementary Material.

Funding

This work was generously supported by BBSRC research grants BB/ M018261/1 and BB/W00285X/1 to D.F.B. and S.J.W.B., and BB/ Y007603/1 and an Aston University BBSRC Impact Acceleration award to D.F.B. The Aston Institute for Membrane Excellence (AIME) is funded by UKRI’s Research England as part of their Expanding Excellence in England (E3) fund. We are grateful to Georgia Isom for providing plasmid pBAD/ letB EPEC .

Keywords

  • Recombinant protein production
  • Escherichia coli
  • Plasmid copy number
  • Membrane proteins

Fingerprint

Dive into the research topics of 'The E. coli lite strains: New expression strains for the production of toxic membrane proteins'. Together they form a unique fingerprint.

Cite this